SCHEMBL29994018

SCHEMBL29994018

CON(C)C(=O)Cc1cccc(Br)c1F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.37
▸ HDAC4 P56524 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ POLQ O75417 1/20 0.34
▸ TRPM8 Q7Z2W7 1/20 0.33
▸ KAT6A Q92794 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ RIPK1 Q13546 1/20 0.33
▸ TAAR1 Q96RJ0 1/20 0.33
▸ SIGMAR1 Q99720 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ OPRM1 P35372 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27094112 1.00 ATM (0.37) ATMHDAC4HDAC6MEN1KMT2A
SCHEMBL13032640 0.84 TAAR1 (0.43) MEN1KMT2ATDP1POLQALDH1A1
SCHEMBL38660431 0.80 KMT2A (0.39) HDAC4HDAC6MEN1KMT2ATDP1
SCHEMBL31284578 0.78 KDM4E (0.43) ATMMEN1KMT2ATDP1ALDH1A1
SCHEMBL27984139 0.78 KDM4E (0.43) ATMMEN1KMT2ATDP1ALDH1A1
SCHEMBL1668464 0.78 ALDH1A1 (0.45) ATMMEN1KMT2APOLQALDH1A1
SCHEMBL27094100 0.76 L3MBTL1 (0.40) ATMMEN1KMT2AALDH1A1RIPK1
SCHEMBL29993025 0.76 L3MBTL1 (0.40) ATMMEN1KMT2AALDH1A1RIPK1
SCHEMBL671835 0.76 PKM (0.44) MEN1KMT2ATDP1ALDH1A1L3MBTL1
SCHEMBL31053240 0.76 PKM (0.44) MEN1KMT2ATDP1ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4323354-B1 2-((4-((S)-2-(4-CHLORO-2-FLUOROPHENYL)-2-METHYLBENZO[D][1,3]DIOXOL-4-YL)PIPERIDIN-1-YL)METHYL)-1-(((S)-OXETAN-2-YL)METHYL)-1H-IMIDAZOLE DERIVATIVES AS ACTIVATORS OF THE GLP1 RECEPTOR FOR THE TREATMENT OF OBESITY NOVARTIS AG (CH) 2025-12-17 — — EP disclosed
EP-4323354-A1 2-((4-((S)-2-(4-CHLORO-2-FLUOROPHENYL)-2-METHYLBENZO[D][1,3]DIOXOL-4-YL)PIPERIDIN-1-YL)METHYL)-1-(((S)-OXETAN-2-YL)METHYL)-1H-IMIDAZOLE DERIVATIVES AS ACTIVATORS OF THE GLP1 RECEPTOR FOR THE TREATMENT OF OBESITY Novartis AG (CH) 2024-02-21 — — EP disclosed
CN-117222644-A 2- ((4- ((S) -2- (4-chloro-2-fluorophenyl) -2-methylbenzo [ d ] [1,3] dioxol-4-yl) piperidin-1-yl) methyl) -1- (((S) -oxetan-2-yl) methyl) -1H-imidazole derivatives as GLP1 receptor activators for the treatment of obesity 诺华股份有限公司 2023-12-12 — — CN disclosed
WO-2022219495-A1 2-((4-((S)-2-(4-CHLORO-2-FLUOROPHENYL)-2-METHYLBENZO[D][1,3]DIOXOL-4-YL)PIPERIDIN-1-YL)METHYL)-1-(((S)-OXETAN-2-YL)METHYL)-1H-IMIDAZOLE DERIVATIVES AS ACTIVATORS OF THE GLP1 RECEPTOR FOR THE TREATMENT OF OBESITY NOVARTIS AG (CH) 2022-10-20 — — WO disclosed
Send feedback